Clinical Trials Logo

Breast Milk Expression clinical trials

View clinical trials related to Breast Milk Expression.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05992753 Completed - Breastfeeding Clinical Trials

Mothers' Breast Milk Expression Experiences, Infant Feeding Attitudes and Perceived Social Support Levels

Start date: September 1, 2022
Phase:
Study type: Observational

Background: Expressing breast milk in cases where breastfeeding is interrupted is important for infants to be fed breast milk however, many factors can affect mothers' breastfeeding experience, such as feeding attitudes and the level of social support. The aim of this study is to determine the relationship mothers' breast milk expression experience between infant feeding attitudes and perceived social support level. Methods: This cross-sectional study was carried out in the postpartum and lactation unit of a city hospital in Istanbul, between September-November 2022. The study included 455 women who were volunteering to participate in the research, 18 years of age or older, in the 0-6 months postpartum period, having a living baby, continuing to breastfeed, and expressing breast milk at least once after birth. Data were collected with Mother-Baby Introductory Information Form, Breast Milk Expression Experience Measure (BMEE), Iowa Infant Feeding Attitude Scale (IIFAS), and Multidimensional Scale of Perceived Social Support (MSPSS). The data were analyzed using the SPSS-21 statistical software package. The main questions it aims to answer are: - Which characteristics affect mothers' breast milk expression experiences, infant feeding attitudes, and perceived social support levels in the early postpartum period? - Is there a relationship between mothers' experiences of breast milk expression and their infant feeding attitudes and social support levels in the early postpartum period?

NCT ID: NCT05599542 Completed - Breastfeeding Clinical Trials

The Effect of Hypno-breastfeeding and Solution-oriented Approach

Start date: December 7, 2021
Phase: N/A
Study type: Interventional

Motivation, which is also necessary for the breastfeeding behavior of mothers in the postpartum period, can affect the success and continuity of breastfeeding. This study was conducted to evaluate the effects of hypno-breastfeeding and solution-oriented approach on breastfeeding motivation and insufficient milk perception in mothers. It is a randomized controlled experimental study. The sample of the study consisted of 90 women who met the inclusion criteria, three groups as the hypno-breastfeeding group, the solution-focused approach group and the control group.

NCT ID: NCT04729166 Completed - Clinical trials for Breast Feeding, Exclusive

The Management of Perceived Breastmilk Insufficiency

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

A randomized control trial was made to determine the effectiveness of structured education and follow-up in the management of perceived milk insufficiency among breastfeeding mothers.

NCT ID: NCT04492579 Completed - Clinical trials for Breast Milk Expression

Newborns Supplemented With Gentle-UHT Donor Milk

Start date: August 3, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effects of providing breastfeeding mothers with Gentle-UHT donor human milk (GHM) after discharge to bridge the gap during delayed onset lactation, to support an exclusive human milk diet and continued breastfeeding through the infant's first week of life. The investigators aim to determine the safety of GHM, and if GHM provided to breastfeeding mothers of outpatient babies with early weight loss will ensure babies adequately gain weight according to age-matched controls.

NCT ID: NCT03674632 Completed - Breastfeeding Clinical Trials

Breastfeed a Better Youngster: the BABY Study

BABY
Start date: November 25, 2018
Phase: N/A
Study type: Interventional

This research will investigate different aspects of the 'signalling' between mother and infant during breastfeeding in a stressful situation following late preterm and early term delivery, when breastfeeding is often challenging. The researcher will conduct a single-blinded randomised controlled trial in Chinese mothers who deliver a late preterm infant (LPI; 34 0/7-36 6/7 weeks of gestation) and mothers who deliver a early term infant (ETI; 37 0/7-37 6/7) and plan to exclusively breast-feed.This study will investigate the role of the milk and infant gut microbiome as a potential 'signal' in this process. A relaxation intervention (meditation tape) will be used to reduce stress levels in mothers who are expressing breast-milk or breastfeeding their infant (born at 34 0/7-37 6/7 weeks completed gestation). This study will investigate whether lower levels of stress in the mother result in more successful and effective breastfeeding, leading to improved infant outcomes (better growth, longer sleep duration and reduced crying).

NCT ID: NCT03617549 Completed - Stress Clinical Trials

Stress and Breast Milk Study In the Neonatal Intensive Care Unit

Start date: June 1, 2019
Phase:
Study type: Observational

The overall goal of this research is to clarify the relationship between reported maternal stress, biological measures of maternal stress, breast milk biomarkers and milk quantity. Our primary hypothesis is that measures of maternal stress are associated with cortisol, cytokines, and other stress markers in the blood, which impacts breast milk quantity and composition and which may impact infant health.

NCT ID: NCT03583502 Completed - Clinical trials for Breast Milk Expression

Krill Oil Supplementation: Effects on Breast Milk Composition

Start date: June 1, 2016
Phase: N/A
Study type: Interventional

Docosahexaenoic acid (DHA) belongs to long-chain polyunsaturated fatty acids (LCPUFAs) category and is a major building block for neuronal and retinal membranes, playing a crucial role in brain and visual development within the first months of life. Due to the lack of enzymes for the synthesis of its precursors, neonates strictly rely on dietary intakes of DHA. Antarctic krill (Euphausia superba) is a small crustacean rich in phospholipid-bound DHA, which is highly bioavailable, but whether it is effective in increasing DHA excretion in breast milk (BM) has not been investigated yet. This study aims to evaluate whether maternal supplementation with krill oil during breastfeeding increases DHA contents in breast milk BM. Mothers of infants admitted to the Neonatal Intensive Care Unit will be enrolled in this open, randomized, controlled study and randomly allocated in 2 groups. Group 1 will receive an oral krill oil-based supplement providing 250 mg/day of DHA and 70 mg/day of EPA for 30 days, whereas group 2 serves as control. BM samples from both groups will be collected at baseline (T0) and day 30 (T1) and will undergo a qualitative analysis of LCPUFAs composition by gas chromatography/mass spectrometry.

NCT ID: NCT01892085 Completed - Clinical trials for Breast Milk Expression

Early Initiation of Milk Expression in Mothers of Very Low Birth Weight Infants

Start date: November 2013
Phase: N/A
Study type: Interventional

Compelling evidence exists that breast milk helps protect very premature infants from prematurity-specific morbidities. Unfortunately, mothers of premature infants often exhibit delayed lactogenesis stage II (when the milk "comes in") and decreased breast milk production. Several studies have linked earlier initiation of breast milk expression following delivery with a greater milk production. However, none conclusively determined the optimal timing of breast milk expression. As a result these mothers continue to struggle with inadequate breast milk production. This study will follow 180 mothers of premature infants for 6 weeks following delivery to test Earlier initiation of breast milk expression following delivery is associated with (1) an earlier lactogenesis stage II, (2) greater volume of breast milk production during the first 6 weeks, (3) improved short-term infant health outcomes and (4) women who deliver at an earlier gestation will have decreased milk production and a later lactogenesis stage II. Following stratification according to the gestational age of the infant (23-27 weeks vs. 28-32 weeks), eligible women will be randomly assigned to one of three groups and instructed to start mechanically expressing their r breasts, either in the first hour, 1-3 hours or 3-6 hours following delivery. The timing of lactogenesis stage II will be documented, and the volume of breast milk produced will continue to be measured for the first 6 weeks following delivery and at discharge. Infant nutritional outcomes will be measured throughout the 6-week study. The impact of the differences in timing of initiation of milk expression following delivery on timing of lactogenesis stage II, milk volume, short term nutritional outcomes, amount of breast milk feedings at discharge, and impact of gestational age on milk volume and lactogenesis stage II will be determined.